Search results
Biden plan to save Medicare patients money on drugs risks empty shelves, pharmacists say
San Jose Mercury News· 6 hours agoMonths into a new Biden administration policy intended to lower drug costs for Medicare patients,...
Increasing number of employers covering GLP-1 drugs for weight loss, survey finds
BenefitsPRO· 8 hours agoInsurer resistance to covering the drugs is a limiting factor for sales growth for drugmakers,...
$2,000 Cap On Out-Of-Pocket Drug Costs To Help Millions Of Medicare Beneficiaries
Forbes· 2 days agoThe Inflation Reduction Act’s cap of $2,000 on annual out-of-pocket spending on outpatient drugs...
Trump’s Anti-Vaccine Problem
New York Times· 2 hours agoFormer President Donald Trump’s chaotic and denial-filled response to the Covid-19 pandemic turned off independent voters and arguably cost him the 2020...
Michigan insurer plans to drop coverage for weight loss drugs
The Hill· 3 hours agoBlue Cross Blue Shield of Michigan is one such insurer. Companies aren’t entirely rejecting the drug...
Fact check: Trump falsely claims Biden didn’t lower Americans’ insulin costs
CNN via AOL· 5 hours agoUnder Trump’s program, the voluntary $35 monthly cap only applied to insulin obtained via Medicare...
Why Blue Cross of Michigan is axing coverage of popular weight loss drugs
Detroit News· 2 days agoBlue Cross Blue Shield of Michigan is dropping coverage of popular weight loss drugs, citing...
Eli Lilly unveils new manufacturing plant for GLP-1 pens
Yahoo Finance via AOL· 3 hours agoEli Lilly's new facility in Concord, N.C. Yahoo Finance The Concord facility alone has cost the...
Supreme Court Rejects Challenge to FDA Approval of Mifepristone on Standing, but the Battle...
The National Law Review· 2 hours agoOn June 13, 2024, a unanimous Supreme Court held that physicians and medical associations opposed to...
Novo Nordisk CEO to testify in US Senate hearing on high cost of Ozempic, Wegovy
AOL· 2 hours agoA U.S. Senate health panel vote that was scheduled for its June 18 meeting, to decide whether to subpoena Novo to answer questions about U.S. prices for the blockbuster drugs, is no longer necessary ...